GlassScriptPhysician profile
Shwetha Manoharan
NPI 1750792412
$1,137.91
in general payments reported to CMS, 2019-2025
20 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $60.87 · 2021: $94.28 · 2022: $250 · 2023: $66.10 · 2024: $148 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $192.55 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $160.04 | 2019-2022 | |
| Avion Pharmaceuticals | $121.97 | 2019-2021 | |
| Coopersurgical, INC. | $111.39 | 2022-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Sage Therapeutics, LLC | $80.79 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $62.67 | 2022-2025 | |
| Hologic Sales and Service, LLC | $60.07 | 2024 | Novasure, Myosure Tissue Removal Device |
| Minerva Surgical, INC | $52.32 | 2019 | |
| Mission Pharmacal Company | $40.55 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $35.01 | 2019 | |
| Exeltis, USA INC. | $32.25 | 2024-2025 | Slynd |
| Merck Sharp & Dohme LLC | $31.73 | 2019 | |
| Conmed Corporation | $28.18 | 2023 | Airseal |
| Therapeuticsmd, INC. | $26.02 | 2019-2021 | |
| Astellas Pharma US INC | $23.95 | 2025 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $21.88 | 2025 | Dexcom G6 Transmitter |
| Millicent US INC | $18.88 | 2025 | Femlyv |
| Amag Pharmaceuticals, INC. | $13.40 | 2019 | |
| Meditrina | $12.83 | 2021 | |
| Agile Therapeutics, INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shwetha Manoharan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.